Wang Chung Han. INTRODUCTION Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder resulting from a CAG expansion in the huntingtin.

Slides:

Advertisements

Similar presentations

Mendelian Genetics.

Advertisements

Stine N Hansen 1,2, Noreen A Alexander 1,2, Carina von Schantz 3, Outi Kopra 3, Anu Jalanko 3, Jonathan D Cooper 1,2 Neuropathological and reactive changes.

Chromosome Disorders. Classification of genetic disorders  Single-gene disorders (2%)  Chromosome disorders (

Huntington’s Disease.

Lecturer: Dr Lucy Patston  Thank you to the following 2013 Year Two students who devoted their time and effort to developing the.

 Dominant neurodegenerative disease  Polyglutamine repeat expansions (CAG, codon, Q) in exon 1 of huntingtin gene (htt). Usually >35 CAG repeats. 

Two copies of each autosomal gene affect phenotype.

Huntington’s disease Also called Huntington Chorea, affects men and women. 4 to 10 cases in 100,000 people (frequency between 0.004% and 0.01%) . Chorea.

Behavior Chapter 12. Central Points (1)  Behavior is a reaction to environment  Animals and humans have similar behaviors  Brain chemicals important.

PHL 437/Pharmacogenomics Fourth Lecture (Parkinson’s disease) By Abdelkader Ashour, Ph.D. Phone:

Parkinson’s Disease Pathology 430/826 The Molecular Basis of Disease Neurological Genetics 9 th March 2015 Dr. John Rossiter

Huntington’s Disease. Huntington's Disease is an autosomal dominant genetic disorder Meaning that if a parent has Huntington's there is a 50% chance the.

Module 7.3 Movement Disorders. Parkinson’s Disease A neurological disorder characterized by muscle tremors, rigidity, slow movements and difficulty initiating.

Gene Therapy in Huntington’s Disease Project was done by Rejan Chin & Sharisa Ford.

What is Huntington’s disease? It is a progressive degeneration of the nerve cells in the brain. This disease cause uncontrolled movements, emotional problems,

By: Kaila Cooper What is it? Huntington’s Disease s a brain disorder that affects a person’s ability to think, talk, and move.

Huntington’s Disease Michael Ou Pierce Lam.

Complex Patterns of Inheritance and Meiosis inheritance mistakes.

AMPAKINE Compounds for the Treatment of Rett Syndrome

Global and Regional Brain Morphology in Subjects with Huntington’s Disease Prior to Diagnosis Peg C. Nopoulos 1,2,4, Hans J. Johnson 1, Vincent A. Magnotta.

The use of Pan-PPAR Agonists for Treatment of Tauopathies and Huntington’s disease Inventor: Flint Beal, MD Chairman of Neurology and Neuroscience/Neurologist-in-Chief.

Introduction Dry eye is a condition in which there are insufficient tears to lubricate and nourish the eye. An estimated 25 million Americans are affected.

7.1 Chromosomes and Phenotype KEY CONCEPT The chromosomes on which genes are located can affect the expression of traits.

Subcortical Motor Systems: Cerebellum & Basal Ganglia Lecture 21.

7.1 Chromosomes and Phenotype KEY CONCEPT The chromosomes on which genes are located can affect the expression of traits.

OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells (Irina V. Kovtun et al., Nature, 2007) Yizhang Chen 10/18/2012 Student Presentation.

Non-motor symptoms of PD revealed in mice with reduced vesicular storage Tonya Taylor MSP Symposium May 29, 2009.

Effects of matrix metalloproteinase-9 on insulin survival pathways in Alzheimer’s disease Introduction Defective brain insulin signaling has been suggested.

PARTIAL LOSS OF TIP60 SLOWS MID-STAGE NEURODEGENERATION IN A SPINOCEREBELLAR ATAXIA TYPE 1 (SCA1) MOUSE MODEL -KRISTEN M. GEHRKING, J. MICHAEL ANDRESEN,

Clinical Features Huntington’s disease is a rapidly progressive neurodegenerative disease that leads to dementia. Typically presents with alterations.

Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.

Anjali Sivendra Yanique Bell February 1, 2010 Period 9/10.

HUNTINGTON’S DISEASE By Clark Jones, Michael Brunk, and Trevor Peterson.

DAY 2 Unit 3 Inheritance and Molecular Genetics 1.

Disease That Result from Expansion of Trinucleotide Repeats Tianyang Wang.

The Genetics and Molecular Biology of Huntington’s Disease SON DONG, JUSTIN WISE, NIKET YADAV.

GENETICS Dr. Samar Saleh Assiss. Lecturer Mosul Medical College Pathology3 rd year.

STEM CELL RESEARCH ON HUNTINGTON’S DISEASE Josh Merrifield, Michael Jennings, and Stephanie Antone.

Huntington's Chorea Huntington's Disorder. Causes  Huntingtin Gene (HTT)  Length of Gene  Huntingtin Protein (Htt)  Mutation (mHtt)

Sex-Linked Traits. Inheritance of Traits  X-linked Disorders - occur mainly in males because the mother usually donates the recessive allele and males.

AMERICAN PHYSIOLOGICAL SOCIETY EDUCATION COMMITTEE Refresher Course 2002: Recent Advances in Neuroscience Stem Cells, Growth Factors and Neurodegeneration.

Reflections on animal models of neurological disorders Marie-Francoise Chesselet UCLA

(Draw and label a picture of a neurone here)

MITOCHONDRIA AND HUNTINGTON'S DISEASE

Two copies of each autosomal gene affect phenotype.

Two copies of each autosomal gene affect phenotype.

Two copies of each autosomal gene affect phenotype.

Two copies of each autosomal gene affect phenotype.

Two copies of each autosomal gene affect phenotype.

Huntington's Disease: Can Mice Lead the Way to Treatment?

Autosomal dominant inheritance: the basics

Inherited Metabolic Disorders

Two copies of each autosomal gene affect phenotype.

Volume 83, Issue 1, Pages (July 2014)

Two copies of each autosomal gene affect phenotype.

Two copies of each autosomal gene affect phenotype.

S3: HEREDITY E1: SEX-LINKED TRAITS

Huntington’s Disease Case presentation Clinical features Pathology

FUNCTIONS OF THE BASAL NUCLEI FUNCTIONS OF THE BASAL NUCLEI assist in the regulation of voluntary movement & the learning of motor skills initiate movement.

Two copies of each autosomal gene affect phenotype.

Fig. 1. Bexarotene promotes PPARδ activation to ameliorate the neurotoxicity of mutant huntingtin. Bexarotene promotes PPARδ activation to ameliorate the.

Volume 21, Issue 10, Pages (December 2017)

Two copies of each autosomal gene affect phenotype.

Two copies of each autosomal gene affect phenotype.

Two copies of each autosomal gene affect phenotype.

Miguel G. Salom, Bárbara Bonacasa Kidney International

Engineering of D1- or D2-MSN-specific YCnano50 or ArchT-EGFP mice.

Two copies of each autosomal gene affect phenotype.

Two copies of each autosomal gene affect phenotype.

Gene expression in the PFC of mice with an inducible neuron-specific bdnf knock-out in embryogenesis. Gene expression in the PFC of mice with an inducible.

Presentation transcript:

Wang Chung Han

INTRODUCTION Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder resulting from a CAG expansion in the huntingtin gene. The earliest signs of pathology in HD are in the striatum, a subcortical structure involved in the control of movement and action selection. parallel projection systems direct pathwayindirect pathway promotes actionsuppresses action

In recent years, this loss has been attributed to impaired expression and release of brain-derived neurotrophic factor (BDNF) by corticostriatal terminals. The BACHD mouse is a transgenic model of HD in which the full-length human mutant huntingtin (mHtt) gene has been inserted using a bacterial artificial chromosome (BAC). These mice display progressive motor and physiological deficits that are pronounced by 6 months of age. This also was true in the Q175 knockin mouse model of HD, which displays a similar progressive motor and physiological phenotype.

BDNF signal pathway Nature Reviews Neuroscience 10, (December 2009) BACHD mice normal Q175 mice impaired

BDNF Expression and Delivery to the Striatum Was Normal in HD Mice

No change in TrkBR expression in symptomatic (5–6 months old) BACHD mice

Signaling Downstream of TrkBRs Is Attenuated in the BACHD Striatum